Login / Signup

Myasthenia Gravis and COVID-19: A Systematic Review and Meta-analysis.

Amirhossein NafariSeyedpouzhia ShojaeiReza Jalili KhoshnoodMahsa GhajarzadehArash TafreshinejadSaeid SafariOmid Mirmosayyeb
Published in: Basic and clinical neuroscience (2024)
In summary, this systematic review and meta-analysis reveal that the pooled prevalence of COVID-19 infection in individuals with MG is 2%.
Keyphrases
  • myasthenia gravis
  • coronavirus disease
  • sars cov
  • risk factors
  • genome wide
  • single cell
  • respiratory syndrome coronavirus
  • gene expression
  • randomized controlled trial
  • dna methylation
  • study protocol